Install our extension to search inside any video instantly.

Prime Time | CJP Protest Continues | U.S. Drug Tariffs | Ukraine Commander Replaced

Added:
102 views2likes33:00IndiFokusNewsOriginal Release: 2026-07-23

The United States has implemented a new phased tariff regime on imported generic medicines, with tariffs starting at 0% for a 2-year period, then increasing to 100% for one year, and finally 200% thereafter. This policy aims to reshore generic pharmaceutical production to America by penalizing companies that do not build manufacturing facilities within the specified timeframe. The announcement comes during trade negotiations with India, which is the world's largest exporter of generic medicines, having exported nearly $8.5 billion worth of medicines to the US in 2026, representing one-third of India's total pharmaceutical exports. Indian companies supply approximately 40% of generic medicines used in the US by volume. The timing of this announcement, coming just before the July 24th deadline for India-US trade deal negotiations, raises significant concerns about how India will protect its pharmaceutical sector, which remains its biggest export industry.